ArticleBipolar disorders2026
Psychometric Properties of the Turkish Version of the Rapid Mood Screener for Bipolar Disorder (RMS-T): A Validity and Reliability Study.
Article in Bipolar disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveThe Rapid Mood Screener (RMS) is a reliable and validated brief, point-of-care, patient-administered screening tool for bipolar disorders. Herein we aim to evaluate the reliability and validity of the RMS in Turkish adults with bipolar I disorder (BD).
methodForward and backward translation was conducted for the English version of the RMS to the Turkish version of RMS (RMS-T). We conducted a ROC analysis for both the Mood Disorder Questionnaire (MDQ) and RMS-T in adults with major depressive disorder (MDD) or BD. The maximum sensitivity and specificity were also calculated.
resultsWe recruited 128 participants (n = 63 BD-I, n = 65 MDD). Participants who responded 4 or more "yes" out of six items on the RMS-T were adjudicated as a positive screen for BD-I. The sensitivity of the RMS-T was 79.4% and the specificity was 84.6%. The RMS-T was determined to be of higher discriminative power in discriminating BD relative to the MDQ (AUC = 0.865, p < 0.001).
conclusionThe RMS-T is a valid and easy-to-use self-administer tool for the identification of BD-I in individuals with depression. The RMS has many advantages over the MDQ in clinical settings by having fewer items, a simpler scoring system, and shorter completion time. Early screening and detection of BD is critical for appropriate treatment selection to achieve the goal of overall improving health outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.